This 4C for Q2 22/23 FY is going to be very ordinary and doesnt have much relevance. All the focus was on the FDA approval and then getting the HP Pro product out which i understand will ship soon which will also be invoiced up front. Then there is the RealTek stuff to come. This is going to give a better indication of things than the Q2 4C.
Quarterly- how bad?, page-15
Add NUH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NUH (ASX) Chart |
Day chart unavailable